Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin for treatment of COVID-19 infection
IRCT20190624043993N3Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of isotretinoin in coronavirus disease 2019 (COVID-19), sponsored by Kermanshah University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
isotretinoin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20190624043993N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043993N3.